DGAP-News: Formycon Reports First Quarter 2022 Financial Results and Announces Development Start of two New Biosimilar Candidates FYB208 and FYB209
|
DGAP-News: Formycon AG
/ Key word(s): Quarter Results
Formycon Reports First Quarter 2022 Financial Results and Announces Development Start of two New Biosimilar Candidates FYB208 and FYB209 21.06.2022 / 07:30 The issuer is solely... |